The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.
Prescription-drug marketer AstraZeneca Pharmaceuticals is in the early stages of planning a media buying consolidation, sources said. The combined account will be worth an estimated $100 million in billings.
The Wilmington, Del.-based client has quietly begun contacting its roster shops about a review and is developing a request for proposals to send to contenders, sources said.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in